MarketInOut Stock Screener Log In | Sign Up
 

Zoetis Inc

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/29/2026
Zoetis Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization32,813 mln
Float418 mln
Earnings Date08/11/2026

EPS

6.10
Strong

P / E

12.73
Fair value

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.47
Borderline

1-Year Forecast

125
Transformational upside

Relative Strength

78 / 100
Strongly outperforming

Business Description

Zoetis is a global animal health company that develops and sells medicines, vaccines, and diagnostic tools for both pets and farm animals. Its products serve a wide range of species, from dogs and cats to cattle, poultry, and fish, reaching customers through veterinarians, farmers, and pet owners. Founded in 2012 and based in New Jersey, the company also invests in emerging areas such as genetic testing and precision health technologies to advance the care of animals worldwide.

Key Fundamentals

EPS6.10
P/E12.73
ROE61.20
RPS21.74
ROIC25.10
ROA17.77
Interest Cover15.53
EBITDA, mln4,025
EV / EBITDA10.14
EV / EBIT11.54
Revenue, mln9,509
EV / Revenue4.29

Financial Strength

Altman Z-Score4.75
Piotroski F-Score 8 / 9
Beneish M-Score-2.47
Price to Intrinsic Value1.33
Price to Lynch Fair Value1.38
1-Year Target Price125
Shiller PE Ratio17.28
Short Ratio1.79
Short % of Float3.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.97% 13 / 100   
1 Month -31.75% 1 / 100   
2 Months -39.41% 1 / 100   
6 Months -38.73% 3 / 100   
1 Year -52.3% 3 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us